Literature DB >> 24167464

Delineation of a de novo 7q21.3q31.1 Deletion by CGH-SNP Arrays in a Girl with Multiple Congenital Anomalies Including Severe Glaucoma.

L Martínez-Jacobo1, C Córdova-Fletes, R Ortiz-López, F Rivas, C Saucedo-Carrasco, A Rojas-Martínez.   

Abstract

In this study, we present a female patient with a constitutional de novo deletion in 7q21.3q31.1 as determined by G-banding and CGH-SNP arrays. She exhibited, among other features, psychomotor retardation, congenital severe bilateral glaucoma, a cleft palate, and heart defect. Microarray assay disclosed a deleted 12.5-Mb region roughly 88 kb downstream the ectrodactyly critical region; thus, the patient's final karyotype was 46,XX.arr 7q21.3q31.1(96,742,140-109,246,085)×1 dn. This girl represents the fourth patient described so far with congenital glaucoma and a deletion encompassing or overlapping the 7q21.3q31.1 region, and confirms the presence of a locus or loci related to such a clinical feature. According to our results, the proneness to ocular defects secondary to 7q intermediate deletions could be caused by co-deletion of TAC1, HBP1, and a small cluster of cytochrome P450 genes (subfamily 3A). This conclusion is supported by their functional roles and expression locations as well as because TAC1 is related to the functional pathway of the MYOC gene whose mutations are linked to glaucoma. Moreover, given that this girl is clinically reminiscent of several phenotypes related to diverse deletions within 7q21q32, our results and observations offer a general overview of the gene content of deletions/phenotypes overlapping 7q21.3q31.1 and confirm that loci distal to DLX genes including the CUX1 gene and potential regulatory elements downstream from DLX5 are unrelated to ectrodactyly.

Entities:  

Keywords:  Array-CGH; Candidate genes; Delineation del(7q); Ectrodactyly region

Year:  2013        PMID: 24167464      PMCID: PMC3776397          DOI: 10.1159/000353510

Source DB:  PubMed          Journal:  Mol Syndromol        ISSN: 1661-8769


  39 in total

1.  Ectro-amelia syndrome associated with an interstitial deletion of 7q.

Authors:  M A Morey; R R Higgins
Journal:  Am J Med Genet       Date:  1990-01

2.  Drug transporter and cytochrome P450 mRNA expression in human ocular barriers: implications for ocular drug disposition.

Authors:  Tao Zhang; Cathie D Xiang; David Gale; Samantha Carreiro; Ellen Y Wu; Eric Y Zhang
Journal:  Drug Metab Dispos       Date:  2008-04-14       Impact factor: 3.922

3.  Interstitial deletion of the long arm of chromosome no. 7 (7q-) in an infant with multiple anomalies.

Authors:  G Higginson; D D Weaver; R E Magenis; G H Prescott; C Haag; D J Hepburn
Journal:  Clin Genet       Date:  1976-11       Impact factor: 4.438

4.  Prenatal diagnosis and molecular cytogenetic characterization of a de novo interstitial deletion of 7q (7q22.1→q31.1).

Authors:  Chih-Ping Chen; Shing-Jyh Chang; Schu-Rern Chern; Peih-Shan Wu; Yu-Ting Chen; Jun-Wei Su; Wen-Lin Chen; Wayseen Wang
Journal:  Gene       Date:  2013-03-29       Impact factor: 3.688

5.  Interstitial 7q deletion [46,XX,del(7)(pter----q21.1::q22----qter)] and the location of genes for beta-glucuronidase and cystic fibrosis.

Authors:  D Chitayat; B C McGillivray; S Wood; D K Kalousek; S Langlois; D A Applegarth
Journal:  Am J Med Genet       Date:  1988-11

6.  Interstitial deletion of the long arm of chromosome 7.

Authors:  L Serup
Journal:  Hum Genet       Date:  1980       Impact factor: 4.132

7.  Cat-like cry and mental retardation owing to 7q interstitial deletion (7q22 leads to 7q32).

Authors:  D N Abuelo; T Padre-Mendoza
Journal:  J Med Genet       Date:  1982-12       Impact factor: 6.318

8.  Terminal and interstitial deletions of the long arm of chromosome 7: a review with five new cases.

Authors:  R S Young; D D Weaver; M K Kukolich; N A Heerema; C G Palmer; E L Kawira; H A Bender
Journal:  Am J Med Genet       Date:  1984-02

9.  Cystatin a, a potential common link for mutant myocilin causative glaucoma.

Authors:  K David Kennedy; S A AnithaChristy; Lakisha K Buie; Teresa Borrás
Journal:  PLoS One       Date:  2012-05-15       Impact factor: 3.240

10.  COG5-CDG: expanding the clinical spectrum.

Authors:  Daisy Rymen; Liesbeth Keldermans; Valérie Race; Luc Régal; Nicolas Deconinck; Carlo Dionisi-Vici; Cheuk-Wing Fung; Luisa Sturiale; Claire Rosnoblet; François Foulquier; Gert Matthijs; Jaak Jaeken
Journal:  Orphanet J Rare Dis       Date:  2012-12-10       Impact factor: 4.123

View more
  4 in total

1.  DLX4 is associated with orofacial clefting and abnormal jaw development.

Authors:  Di Wu; Shyamali Mandal; Alex Choi; August Anderson; Michaela Prochazkova; Hazel Perry; Vera L Gil-Da-Silva-Lopes; Richard Lao; Eunice Wan; Paul Ling-Fung Tang; Pui-yan Kwok; Ophir Klein; Bian Zhuan; Anne M Slavotinek
Journal:  Hum Mol Genet       Date:  2015-05-07       Impact factor: 6.150

Review 2.  The HMG box transcription factor HBP1: a cell cycle inhibitor at the crossroads of cancer signaling pathways.

Authors:  Emeline Bollaert; Audrey de Rocca Serra; Jean-Baptiste Demoulin
Journal:  Cell Mol Life Sci       Date:  2019-01-25       Impact factor: 9.261

3.  Germline large genomic alterations on 7q in patients with multiple primary cancers.

Authors:  R A R Villacis; T R Basso; L M Canto; A F Nóbrega; M I Achatz; S R Rogatto
Journal:  Sci Rep       Date:  2017-01-31       Impact factor: 4.379

4.  Copy number variants in Ebstein anomaly.

Authors:  Andreas Giannakou; Robert J Sicko; Wei Zhang; Paul Romitti; Marilyn L Browne; Michele Caggana; Lawrence C Brody; Laura Jelliffe-Pawlowski; Gary M Shaw; Denise M Kay; James L Mills
Journal:  PLoS One       Date:  2017-12-07       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.